Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
A Phase I Trial of Talimogene Laherparepvec for the Treatment of Peritoneal Surface Malignancies (TEMPO)
Clinical Trial Grant
Duke Scholars
Principal Investigator
Dan German Blazer III
Surgical Oncology
Awarded By
Amgen, Inc.
Start Date
February 20, 2019
End Date
February 20, 2025
Awarded By
Amgen, Inc.
Start Date
February 20, 2019
End Date
February 20, 2025
